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 Hormone-sensitive lipase (HSL) is thought to be the major enzyme responsible 
for the release of free fatty acids from adipose tissues. HSL hydrolyses triacylglycerides 
to diacylglyceride, releasing free fatty acids from fats (lipolysis). Using RNAi to silence 
the gene would be advantageous in the study of obesity, so three highly effective 19-
nucleotide short hairpin RNAs (shRNAs 1-3) were designed against the HSL gene.  Their 
ability to reduce HSL protein levels was verified in human 293 cells using immunoblots. 
shRNA-2 sequence was inserted into an adenovirus genome, and a high titer viral 
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2.1. Post-Transcriptional Gene Silencing (PTGS) 
2.1.1. History and Discovery of Gene Silencing 
Two forms of gene silencing have been discovered: transcriptional gene silencing 
(TGS), and post-transcriptional gene silencing (PTGS). TGS involves the gene-specific 
methylation which helps prevent the synthesis of unwanted RNA in the cell. PTGS is a 
complex mechanism involving RNA inhibition or interference (RNAi), small inhibitor 
RNAs (siRNAs) or microRNAs (miRNAs), and double-stranded RNA nucleases, and this 
process affects RNA synthesis and degradation. For the purpose of this MQP, the focus 
will be upon post-transcriptional gene silencing. The PGTS process was first noticed in 
plants such as petunias (Baulcombe, 1996), and was considered for a long time to be a 
rare phenomenon. Research has since found that PTGS has many applications in 
scientific research, and the discovery of more organisms that use this mechanism has lead 
to many uses of gene silencing technology in the laboratory. 
The original discovery of gene silencing began with Rich Gorgenson and his 
study of petunias (Napoli, et al., 1990). When he and his colleagues introduced a 
pigment-producing gene into petunias under the control of a previously powerful 
promoter, it was expected that the flowers would produce a richer purple color. Instead, 
the flowers were pale or even white (Napoli, et al., 1990; Ambion, 2002). At that time, 
this process was called cosuppression due to the fact that both the petunia’s natural 
color genes as well as the introduced gene were suppressed (Ambion 2002). 
Cosuppression was later found to exist in a number of organisms, particularly 
fungi such as Neurosporra crassa, flies such as Drosophila melanogaster, nematodes 
such as C. elegans, and many forms of bacteria (Mechler, 2002). Through the study of 
mutations in gene silencing, several proteins have been found to be involved in the PTGS 
process including PPD, Dicer, Helicases, and RNA dependent RNA polymerase (RdRP). 
Mutations in the genes for these proteins inhibit some, but not all, of PTGS activity 
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(Mechler, 2002).  Gene silencing can be induced by in the introduction of transgenes or 
certain viruses into cells, and from recent experiments is has been determined that double 
stranded RNA (dsRNA) can initiate the gene silencing within plants, nematodes, and flies 
(Ambion, 2002).  In fungi, the process of PTGS through the introduction of a transgene is 
known as quelling. The injection of dsRNA was shown to completely silence 
homologous gene expression in nematodes (Fire, et al., 1998). The injection of dsRNA 
into cells to induce PTGS is now known as RNA interference (RNAi). 
 
2.1.2. PTGS: The Mechanism of Gene Silencing and RNAi 
 The effects of gene silencing are noticed in the cytoplasm, rather than in the genes 
themselves. Transcripts of genes are produced, but they are rapidly degraded in the 
cytoplasm and thus do not accumulate or translate into proteins. Importantly, the specific 
genes which are supressed have 3 sequences that are identical to, or very similar to, the 
dsRNA which is introduced into the cell (Watson, 2004).  
 The RNaseIII-like enzyme known as Dicer (Figure-1) recognizes and digests the 
long dsRNA into smaller fragments. These fragments, which are typically about 23 
nucleotides long, are often called small interfering RNAs (siRNAs) and are responsible 
for the inhibition of the homologous mRNA. SiRNAs can also be manufactured outside 
of the cell and introduced in the laboratory. These siRNAs trigger the destruction of the 
mRNA from the homologous gene; they inhibit the translation of that mRNA, and at 
times they induce modifications in the chromatin within the promoter of the homologous 
gene to silence the gene (Watson, 2004).  
 Several processes take place which lead to this inhibition within the cell, and most 
of them use the same cellular machinery. Proteins from the Argonaut family interact with 
the siRNA to form a complex known as RISC (RNA-induced silencing complex) (Figure-
1, center of the diagram) (RNAi Web, 2004). The siRNA is denatured in an ATP-
dependent manner (Watson, 2004) and the RISC complex binds to a strand mRNA 
transcribed from the homologous gene that is complementary to that of the siRNA. 
Depending upon the match between the siRNA and the target mRNA, the mRNA is 
either silenced or degraded by a nuclease property of RISC (Figure 1, bottom of the 
diagram) (Watson, 2004). 
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 RISC can also enter the nucleus and associate with complementary stands of 
homologous DNA to the siRNA in order to silence the gene. The complex binds to the 
complementary region and recruits other proteins which modify the chromatin around the 
gene, which silences transcription. 
Figure 1:  RNAi as induced by siRNA (Shapiro, 2003) 
 
 The process of RNAi is expremely efficient; only small amounts of dsRNA need 
be introduced into a cell in order to incite gene silencing because the siRNAs are 
recycled. The strenth of this reaction is further increased by RNA-dependent RNA 
polymerase, which is required in many cases of RNAi, and amplifies the siRNA after it is 
recruited to the mRNA by the original siRNA (Watson, 2004). 
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2.1.3. Applications of Gene Silencing in the Laboratory and Research 
 Potential uses for gene silencing as a functional genomics tool are the focus of 
much research. RNAi can be used to ascertain the fuction of specific genes; a gene in a 
cell may be selectively silenced and the resulting effects upon the cell can then be 
determined. Transfection of siRNAs is beginning to be widely used in mammalian cell 
systems (Ambion, 2002). Originally, siRNAs were produced synthetically chemically, 
but now methods that allow for in vitro transcription of siRNAs from plasmids or viruses 
are sometimes used. These vectors can be constructed to express small, tight double-
stranded hairpin loops termed short hairpin RNAs (shRNAs) that get recognized like 
siRNA and carry out gene specific silencing.  A number of companies also produce 
custom siRNAs as a service industry to the biotech industry, and microinjection of these 
RNAs is also a common method for introducing siRNAs into the cell.  
 
2.1.4. pQuiet Plasmid as a Vector for Inducing RNAi 
 The pQuiet plasmid (Figure-2) is one such vector that expresses small hairpin 
loops of RNA for gene silencing. It was 
developed and is commercially available 
through Welgen, Inc. (Worcester. MA).  
This system has been widely used in 
different academic and industrial settings. 
Several authors silencing important genes 
have reported success with this system 
(Sheng et al, 2006; Miyoshi et al., 2006). 
pQuiet-U6 uses the human U6 snRNA 
promoter (yellow in the diagram) to direct 
the expression of the desired siRNA 
sequence for RNAi (Luo and Wang, 2004). 
A short cDNA containing the siRNA of interest can be ligated into the plasmid adjacent 
to the promoter (red in the diagram). Several common cut sites present in the shRNA 
domain include an Spe I site, an Mlu I site, and a Cla I site.  The plasmid can be 
transfected into bacterial cells plated on tetracycline plates to validate a successful DNA 
Figure 2:  pQuiet-U6 Plasmid Vector 
(Luo and Wang, 2004). 
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insertion.  This plasmid can also be easily converted into an adenovirus vector using the 
SpeAd procedure (Luo and Wang, 2004). 
2.2. Adenovirus Packaging 
 Once a vector has been constructed and validated using standard genetic 
engineering techniques to contain the correct gene of interest, the pQuiet plasmid can 
then be integrated into an adenovirus to be used to infect mammalian cells to deliver the 
siRNA sequence.  Adenoviruses are double-stranded DNA 
viruses that are classified as nonenveloped icosahedral viruses 
(Figure 3). The adenovirus genome is linear dsRNA about 35 
Kbp of which about 30 Kbp can be replaced with foreign 
DNA (Wikipedia, 2006).  The virus is able to replicate in the 
host cell’s nucleus using the cell’s own replication machinery, 
although it does encode for it’s own DNA polymerase and 
packaging proteins (Hunt, 2005).  
 Adenoviral infection falls under the following 
categories: productive, abortive, or latent (Figure-4). In 
productive infections, the viral genome is transcribed in the 
nucleus, allowing mRNA from the virus to be translated in the 
cytoplasm. Virions also self-assemble within the nucleus, and virus-host recombinants 
can also be found). In latent infections, and in transformed and tumor cells, viral DNA is 






Figure 3: Adenovirus (Wikipedia, 2006) 
Figure-4:  Various Means of Adenovirus Infection (Hunt, 2005). 
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 Productive infection (Figure-5) is one desired route for laboratory use; the virus 
enters the host cell through viropexis or by directly penetrating the membrane (right side 
of the figure).  Adenovirus often prefers epithelial cells. Once inside the host cell, the 
viral DNA is uncoated in steps, and transported to the nucleus (left side of diagram). 
Once the viral DNA resides within the nucleus, it can be transcribed and replicate. 
Adenoviral mRNA undergoes processing in the nucleus before traveling to the cytoplasm 
to be translated into viral proteins using polysomes. Early proteins produced include 
those for transcription, and adenovirus construction, and those that alter the expression of 
host cell genes (Hunt, 2005). The newly synthesized adenovirus proteins then enter the 








The cell then lyses releasing large amounts of the virion into the culture supernatant, 
from which it can be collected and purified. Adenoviral vectors are very efficient at 
transducing target cells in vitro and in vivo, and can be produced at high titres (>1011/ml) 
(Doefler, 2005). 
 
Figure 5: Adenovirus and Host Cell 
Interactions (Doerfler, 2005) 
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2.3. Mouse Hormone-Sensitive Lipase (HSL) 
 Hormone-sensitive lipase (HSL), also known as triacylgyceride lipase (TAG 
lipase), is thought to be the major enzyme responsible for the metabolism of free fatty 
acids (FFA) from adipose tissues (Mulder, et al., 1999). HSL hydrolyses triacylglycerides 
to diacylglyceride, releasing free fatty acids from fats (lipolysis). Studies have shown that 
it is the rate-limiting enzyme for cholesterol ester and diacylglycerol hydrolysis in 
adipose tissue (Kraemer and Shen, 2006). HSL is essential for complete hormone 
stimulated lypolysis. HSL is a neutral intracellular lipase with a broad specificity 
catalyzing the hydrolysis of triacylglycerol, diacylglycerol, monoacylglycerol, and 
cholesteryl esters, as well as retinyl esters; however, it possesses no phospholipase 
activity (Kraemer and Shen, 2006).  
2.4.1 Free Fatty Acids and Metabolism 
 Free fatty acids (FFAs) are an important source of energy for many tissues in 
mammals (Kraemer and Shen, 2006). FFAs circulating in the plasma are thought to be 
derived from tissue lypolysis of stored adipose tissue rather than from the primary 
digestion of food. Adipose tissue is the main storage repository for triacylglycerol and is 
therefore integral in the study of obesity. Hormones and blood sugar levels regulate the 
lypolysis of adipose tissue. Increases in glucagon (associated with low blood glucose) 
and epinephrine (linked with increased metabolic demands) withing the body signal that 
energy is needed, and the oxidation of fatty acids is increased to meet that need. 
Glucagon, norepinephrine, and epinephrine bind to a G-protein-coupled receptor that 
activates adenylate cyclase to produce cyclic AMP; cAMP next activates protein kinase 
A, which phosphorylates (and thus activates) HSL. It has been shown that HSL knockout 
mice are resistant to obesity, although further analysis of lypolysis and adipose tissue 
metabolism must be completed before HSL can be considered for therapeutic treatment 






2.3.2. HSL Gene Mapping 
 The mouse HSL gene sequence is known, so it can be used to design siRNAs 
complementary to it in RNAi strategies.  The mouse HSL gene is located on chromosome 
7, and occupies base pairs 25088287-25104747 (Figure 6).  The genes for digestive 
activity, as well as adipose tissue related genes, are represented (Figure 6, yellow colored 
transcripts) in the mouse mRNAs that are transcribed from this region of the chromosome 
(The Jackson Laboratory, 2006). For more information on the HSL gene, also known as 
the Lipe gene, see Appendices 1-3. 
       Figure 6: Gene Map of Mouse Chromosome 7,  25088287-25104747: HSL gene (MGI, 2006). 
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PROJECT PURPOSE 
 Because of the key role of hormone-sensitive lipase (HSL) in the release of 
circulatory system-damaging fatty acids from stored adipose tissue, HSL might be a good 
target for gene silencing in obese patients via RNAi therapy. A siRNA for HSL gene 
silencing could also have potential in the study of obesity and free fatty acid metabolism.  
The purpose of this MQP was to select and validate various mouse HSL siRNAs.  Three 
short hairpin RNAs (shRNAs), each 19 nucleotides in length (Table-1 in Methods), will 
be cloned into the Spe I/ Mlu I site of the pQuiet-U6 RNA expression plasmid, and the 
inserts will be verified through enzymatic digestion and selective screening. After the 
three plasmids (titled pQmHSL-shRNA1, pQmHSL-shRNA2, and pQmHSL3) are 
verified for the presence of insert, they will be transformed into E. coli cells for 
amplification, and then purified.  Purified plasmid will then be transfected into 293 cells 
to test siRNA expression and HSL protein knockdown by immunoblots. The most 
successful plasmid will be used to create an adenoviral vector with a titer of at least 1 x 
1012 virus particles per milliliter for future in vivo delivery. 
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4. METHODS 
4.1. Construction of pQHSL-shRNA 
 Three short hairpin RNA (shRNA) sequences shRNA-1, -2, and -3 (Table-1) were 
chosen for cloning into RNA expression vector pQuiet-U6 based on the mouse hormone-
sensitive lipase (HSL) gene sequence (Background Figure-6).   
Table 1: siRNAs for Insertion into pQuiet-U6 Plasmid for Testing HSL RNAi in 293 Cells. 
siRNA designation Sequence Base Pair Location 
MHSL-shRNA 1 GCTGGTGACACTCGCAGAA (94-116) 
MHSL-shRNA 2 GCAAGAGTATGTCACGCTA (526-545) 
MHSL-shRNA 3 GCTGAAAGTGGTAGAAGAT (2212-2231) 
 
 All three shRNAs were cloned into the SpeI/ MluI site of the pQuiet-U6 plasmid 
(located immediately downstream from the U6 RNA promoter) using the pQuiet-U6 
vector cloning kit provided by Welgen. Inc.  The DNA sequences were synthesized as 
individual complementary oligomers (whose sense sequence is shown in Table 1) which 
were then hybridized to each other to make double stranded DNAs flanked by SpeI and 
MluI restriction sites.  The vector pQuiet-U6 was cut with MluI and SpeI, then ligated to 
the annealed oligos, to generate plasmids pQmHSL-shRNA-1, -2, and -3.  Ligated 
plasmids were transformed into competent E. coli, and the cells were plated onto LB 
tetracycline plates.  Tetracycline-resistant colonies were grown overnight in liquid 
cultures, and plasmid DNA was prepared from 1 ml of culture. 
 For screening, plasmid DNA was cut with EcoR5 and XbaI to release shRNA 
insert, then analyzed on 1 % agarose gels.  The positive clones were grown in 5 ml LB 
overnight and plasmid DNA was purified with the Qiagen mini-plasmid purification kit. 
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The shRNA sequences were further verified by DNA sequencing through an outside 
source (data not available). 
4.2. Silencing HSL in 293 Cells 
4.2.1 Co-transfection experiments 
 The target gene expression plasmid pCMV-mHSL (encoding murine hormone-
sensitive lipase) and the three HSL RNAi plasmid vectors were transfected into 293 cells.  
The amount of DNA used for each transfection experiment is listed in Table 2.  A control 
shRNA vector containing a non-specific whRnA sequence, known as scramble shRNA, 
was used as a negative control. 
 Table 2: Components of Each Co-Transfection Reaction, for Each Well of a 6-Well Plate. 
 
Scramble 
shRNA mHSL shRNA 1 shRNA 2 shRNA 3 
pCMV-mHSL 
cDNA (target) - 1.0 1.0 1.0 1.0 
pQ-HSL-shRNA - - 2.0 2.0 2.0 
pLep3 vector 
DNA 3.0 2.0 - - - 
Total DNA 3.0 3.0 3.0 3.0 3.0 
                  
 Human 293T cells were grown in a 6-well microtiter plate to a density of about 5 
x 105 cells per ml and then transfected with as indicated in Table 2 using the Lipofection 
2000 reagent. At 48 hours post-transfection, the 293T cells were lysed in SDS-PAGE 
buffer and then subjected to electrophoresis on 10% SDS-PAGE gels. 
4.2.1 Western Blotting 
 Western blot analysis was used to verify HSL protein knockdown via the siRNA 
expression. The Western blot was performed using an HSL antibody, provided by a 
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proprietary customer, at 1:1000 dilution, followed by an HRP conjugated secondary 
antibody. HRP was detected through chemiluminescence using ECL reagents. 
4.3. Construction of Adenovirus AdQmHSL 
 An effective shRNA was chosen for conversion to adenovirus using the SpeAd 
system provided at Welgen, Inc.  The pQmHSL-shRNA-2 vector was digested with Pi-
PsPI, then ligated into an equivalently linearized pLep plasmid that contains the 
remailing adenovirus genome (Adenovirus type-2). The ligation product was packaged 
into a cosmid using Epicentre’s lambda phage packaging kit. The packaging products 
were used to infect E. coli cells. After incubation overnight, the positive clones were 
selected, and cosmid DNA purified. The purified cosmid DNA (2 g) was digested with 
I-Ceu I, and then transfected into 293 cells with Lipofectamine 2000 according to 
manufacturer’s instructions. The 293 cells were grown at 37” C with 5% CO2. The 
adenovirus plaques were seen 7 days after transfection. A low titer of virus 
(approximately 109 virus particles per milliliter (vp/ml) was obtained from a single well 
of a 6-well plate. 
4.4 Amplification and Purification of Adenovirus 
 The low titer of adenovirus was further amplified to 1012 vp/ml using DMEM 
seeded plates. The amplified adenovirus was purified on two sequential cesium chloride 
gradients, and then dialyzed against 1X PBS buffer containing 10% glycerol, pH 7.4, to 
reduce the salt concentration. The purified virus was measured for its titer using a 
spectrophotometer; in a cuvette 10 l of viral sample was added into 990 l 0.1% SDS 
buffer and incubated at room temperature for 15 minutes, the OD was then measured at 
260 nm.  The adenovirus titer was calculated using the following formula, where D is the 
dilution factor: 
adenovirus titer in vp/ml = OD value x D x 1.1 x 10e12 
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RESULTS 
Construction of Plasmids pQmHSL-shRNA-1, -2, and -3 
 The first phase of this project involved ligating three different short hairpin RNAs 
(shRNA-1, -2, and -3) whose sequences were designed to be complementary to the 3 
UTR of hormone-sensitive lipase (HSL) into the pQuiet RNA expression vector.  The 
ligation products were transformed into competent E. coli, and plated onto tetracycline 
medium plates.  Plasmid DNA was prepared from randomly selected tet-resistant 
colonies, then screened by cutting with EcoRV and XbaI to release the 0.5 KB shRNA 
insert.  Positive shRNA-1 colonies (Figure-7) are seen in the first 3 sample lanes (lanes 2-
4).  The upper band is the plasmid vector DNA and the lower band, if present, is the 
successful insert. One colony from the plasmid of lane 1 was chosen for further analysis. 
 
Figure 7:  Restriction digestion screening of plasmid pQmHSL-shRNA-1.  Samples were digested with 
EcoRV and XbaI to release a 0.5 kb insert.  Positives (indicated by white arrows) are seen in lanes 2-4. 
 The screening for pQMHSL-shRNA-2 (Figure-8) shows positives in lanes 2, 3, 4, 
8, and 11.  The sample shown in lane-2 was chosen for further analysis. 
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Figure 8: Restriction digestion screening of plasmid pQmHSL-shRNA-2. Samples were 
digested with EcoRV and XbaI to release a 0.5 kb insert. Positives (denoted by white arrows) 
are seen in lanes 3-5, 8, 11. 
 The screening of plasmid pQmHSL-shRNA-3 (Figure 9) shows positives in lanes 
1 and 2. One colony, represented by lane 1, was chosen for further analysis. 
 
Figure 9: Restriction digestion screening of plasmid pQmHSL-shRNA-3.  Samples were 
digested with EcoRV and XbaI to release a 0.5 KB insert.  Positives (denoted by white 
arrows) are seen in lanes 1-2. 
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Verification of HSL Protein Knockdown by siRNA 
 Co-transfection experiments were performed with human 293T cells to verify a 
successful knock-down of the HSL gene by the three shRNAs. 293T cells were co-
transfected with plasmid DNAs for each of the 3 shRNAs plus plasmid pCMV-mHSL 
(encoding human HSL) as the target vector.  Lysates were prepared from the plasmid 
transfected cells, and analyzed for total cellular levels of HSL protein using an 
immunoblot (Figure-10). Negative controls were transfected with a vector that does not 
produce HSL.  A scrambled sequence control shRNA was included in the experiments 
to ensure the shRNA specificity. Figure 10 shows that each the three shRNAs reduced the 
amount of HSL expression relative to the scrambled shRNA, but shRNA-2 showed the 
best silencing efficiency, removing almost 95% of HSL proteins. 
 
Figure 10:  HSL Immunoblot to test for HSL knock-down in cells co-transfected with 
HSL reporter plasmid and the three shRNAs designed in this MQP.  shRNA-2 
(second from the right) produced the best HSL knockdown. 
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DISCUSSION 
 The selection and validation of three murine HSL siRNAs for construction into 
Adenovirus type 2 was successful. Three short hairpin RNAs (shRNAs), each 19 
nucleotides in length, were cloned into the Spe I/ Mlu I site of the pQuiet-U6 plasmid and 
the inserts were verified through restriction digestion screening and plasmid sequencing.  
One positive colony for each type of shRNA plasmid was chosen for testing in co-
transfection experiments with human 293T cells treated with pCMV-mHSL target 
plasmid and a plasmid encoding shRNAs-1, -2 or -3. Each shRNA reduced the 
expression of HSL protein levels in the 293T cells relative to a scrambled shRNA, and 
shRNA-2 worked best knocking down HSL to undetectable levels.  While all three 
showed a reduction in HSL, shRNA-2 showed almost 95% RNA silencing for the HSL 
gene. The conclusion of this MQP is that shRNA-2 should be the best choice for research 
using RNAi to study hormone sensitive lipase metabolism in mice. The final viral titer of 
AdQmHSL for shRNA-2 was 4.5 x 1012 virus particles per ml for use in such in vivo 
experiments. 
 An example of a future experiment that could be performed with the HSL 
knockdown adenovirus produced in this project with respect to lipid metabolism would 
be one that studies the effects upon adipose tissue when HSL is silenced in that tissue.  In 
2004, a study by the Institute of Molecular Biosciences, University of Graz in Austria, 
determined that a non-obese phenotype of HSL knock-out (HSL-KO) mice retained an 
accumulation of diglycerides in their adipose tissue, which suggests that HSL may be 
responsible for releasing those diglycerides from that tissue, and there may be one or 
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more additional lipases in adipose tissue that preferentially hydrolyzes the first ester bond 
of the triglyceride molecule. They discovered that another enzyme, adipose triglyceride 
lipase (ATGL), catalyzes the initial step in triglyceride hydrolysis (Zimmermann, et al., 
2004). The HSL enzyme, which has 10 times higher affinity for diglycerides over 
triglycerides, then continues with hydrolysis (Zimmermann, et al., 2004). A later study 
by this group also showed that mice could survive with few complications if they were 
HSL-defective, but ATGL-suppressed mice showed fat cell hypertrophy and mild obesity 
(Haemmerle, 2006). The inability to mobilize these fat stores by ATGL leads to energy 
starvation, resulting in reduced energy expenditure, a decline in body temperature, and 
premature death when Atgl(/) animals are stressed by cold exposure or food deprivation 
(Haemmerle, 2006). This was an important discovery considering that prior knowledge 
had lead scientists to believe that HSL was the sole enzyme responsible for adipose tissue 
metabolism. Using this information, a future experiment in which both ATGL and HSL 
are silenced would confirm the fact that ATGL and HSL are the only enzymes involved 
in lipid metabolism in adipose tissue. Another experiment using the adenovirus construct 
designed in this project to silence HSL in cells might be in the study of HSL silencing as 
a weight-loss tool in diabetic or obese mice. Using some form of silencing as a therapy, 
transient HSL reduction could be induced, as compared to the permanent knock-down of 
the gene in HSL-KO mice to ascertain whether a transient reduction in HSL might be 
more clinically manageable. 
 While transgenic mouse knockouts are available for the HSL gene, the creation of 
the adenovirus construct for this MQP appears to be the first case in which mouse HSL 
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Appendix 1: FASTA genomic sequence for Lipe (HSL) 16890 bp long (NCBI 2006) 
 




















































































































































































































































































































































Appendix 2: Transcribed sequence for Lipe (HSL) from NCBI refSeq NM_010719 
(NCBI 2006) 
 
        1 aaggaaaggt gaatgagatg gcgagggtca gcacctgcac aagatgactg agaattcttt 
       61 gttggggtga ctctaacgcg actcctcact attcctgctg tgagggcact tctcgctgct 
      121 tccaggactg cgggtttttt tttggttttt ggtttttggt tttttgtttg tcgttacggt 
      181 gcactgcgcg gttcctttaa tctgagcaga tgggcgggcc aagaccttca gccccaccca 
      241 ttaaaggcgg agctccgcga ggagcctgcc caggattgga tggtttgggg gcctggcagt 
      301 ggtgtgtaac taggattgac tctaagagag gaacttgatc gctggaattg ggccccgcgc 
      361 caggactgga aagaattgat ggagccggcc gtggaatcgg cgcccgtggg ggcccaggcc 
      421 tccaagcagg gcaaagaagg atcgaagaac cgcagtcgca ggcggtggcg aaaaggcaag 
      481 atcaaagcct cagcgttctc acacagcatg gatttacgca cgatgacaca gtcgctggtg 
      541 acactcgcag aagacaatat ggccttcttc tcaagccagg gcccaggaga gacagcacgg 
      601 cggctgtcta atgtctttgc aggtgttcgg gaacaggcac tggggctgga accaacccta 
      661 ggccaactgt tgggtgtggc acaccatttt gacctggaca cagagacacc agccaacgga 
      721 taccgtagtt tggtgcacac agcccgatgc tgcctggcac acctactaca caaatcccgc 
      781 tatgtggctt ctaaccgcaa aagtatcttc ttccgtgcca gccacaacct agcagagctg 
      841 gaggcctacc tggccgccct cacccagctc cgtgctatgg cctactatgc ccagcgcctg 
      901 ctgaccatca accgaccagg agtgctcttc ttcgagggtg atgaaggact caccgctgac 
      961 ttcctgcaag agtatgtcac gctacacaaa ggctgcttct acggccgctg cctgggcttc 
     1021 cagttcacac ctgccatccg gccgttcctg cagactctct ccatcgggct ggtgtccttc 
     1081 ggggagcact acaaacgcaa cgagacaggc ctcagtgtga ccgccagttc cctctttacc 
     1141 ggtggccgat tcgccataga cccagagttg cgtggggctg aatttgaacg catcatacag 
     1201 aacctggatg tgcacttctg gaaagccttc tggaacatca ctgagattga ggtgctgtcg 
     1261 tctctggcca acatggcatc aaccactgtg agggtaagcc gcctgctcag cttgccacct 
     1321 gaggcctttg agatgccact cacctctgat cccaggctca cagttaccat ctcacctccc 
     1381 ttggcacaca cgggaccagc tcctgtgcta gccaggctca tctcctatga cctacgggaa 
     1441 ggacaggaca gcaaggtact caacagcctg gcaaaatctg agggcccacg cctggagctg 
     1501 cgcccacggc ctcaccaagc accccgttca cgggccctgg ttgttcacat ccacggaggc 
     1561 ggctttgtgg cacagacctc taaatcccac gagccctacc tcaagaactg ggcccaggag 
     1621 ctaggagtcc ctatcttctc catcgactac tccctggccc ccgaggctcc ctttccccga 
     1681 gcgctggagg agtgtttttt tgcctactgc tgggctgtca agcactgtga cctgcttggt 
     1741 tcaactggag agcggatatg ccttgcaggg gacagtgcag gtgggaatct ctgcatcact 
     1801 gtgtcccttc gggcagcagc ctatggagtg agggtgccag atggcatcat ggcagcctac 
     1861 ccagttacca ccctgcagtc ctctgcttct ccctctcgtc tgctgagcct catggaccct 
     1921 cttctaccac tgagcgtact ctctaagtgt gtcagtgcct attcagggac agaggcagag 
     1981 gaccattttg actcagacca gaaggcacta ggcgtgatgg ggctggtgca gagagacact 
     2041 tcgctgttcc tcagagacct ccgactgggt gcctcctcat ggctcaactc cttcctggaa 
     2101 ctaagtggac gcaagcccca aaagaccaca tcgcccacag cagagtctgt gcgccccacg 
     2161 gagtctatgc gcaggagtgt gtctgaggca gccctggccc agcctgaggg cttactgggc 
     2221 acagatacct tgaagaagct gacaataaag gacttgagca actcagagcc ttcagacagc 
     2281 cccgagatgt cacagtcaat ggagacactt ggcccctcca caccctctga tgtcaacttt 
     2341 tttctgcggc ctgggaattc ccaggaagag gctgaagcca aagatgaagt gagacccatg 
     2401 gacggagtcc cccgcgtgcg cgctgctttc cctgaggggt ttcacccccg gcgctcaagc 
     2461 caaggtgtcc tccacatgcc cctctacacg tcacccatag tcaagaaccc cttcatgtct 
     2521 cctctgctgg cccctgacag catgctgaag accttgccgc ctgtgcacct tgtggcttgc 
     2581 gctctggacc ccatgctaga tgactcggtc atgttcgcgc ggcgactgcg cgacctgggc 
     2641 cagccggtga cgctgaaagt ggtagaagat ctgccgcatg gcttcctgag cctggcggca 
     2701 ctgtgtcgcg agacccggca ggccacggag ttctgcgtgc agcgcatccg gctgatcctc 
     2761 accccgcctg ctgcaccact gaactgagct ggggacggcg gggggcggca ctaaaagacc 
     2821 tcttgctccc atctgcgcgg gcttccgtta tgagtgcgct ccgagatggg ctccaggccc 
     2881 cctcagtcgg gctgggcggg cgggagtggg ctgtgcctta acttgagaca gtaagtgggg 
     2941 cgggacaggg gccaaaagct gaacctgggg gagggacaca cacacacctg tcactgagac 
     3001 agctggatct gcactctacc actgccttct gctgctgtga ccgacccggc tagtcggttt 
     3061 tgccttttgt aaataaaagt tatttaacta ggccttttaa aaatagggag tgtgttttcc 
     3121 cagcagatgg cagcactgaa ctaaagttgc tgcgaaaggg aaaattagaa tatgtggacc 
     3181 ccgactctag ctttgctcac aaacaaaacc acctaatatg c 
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Appendix 3: NM_010719 Translation (NCBI 2006) 
 
MEPAVESAPVGAQASKQGKEGSKNRSRRRWRKGKIKASAFSHSM 
DLRTMTQSLVTLAEDNMAFFSSQGPGETARRLSNVFAGVREQALGLEPTLGQLLGVAH 
HFDLDTETPANGYRSLVHTARCCLAHLLHKSRYVASNRKSIFFRASHNLAELEAYLAA 
LTQLRAMAYYAQRLLTINRPGVLFFEGDEGLTADFLQEYVTLHKGCFYGRCLGFQFTP 
AIRPFLQTLSIGLVSFGEHYKRNETGLSVTASSLFTGGRFAIDPELRGAEFERIIQNL 
DVHFWKAFWNITEIEVLSSLANMASTTVRVSRLLSLPPEAFEMPLTSDPRLTVTISPP 
LAHTGPAPVLARLISYDLREGQDSKVLNSLAKSEGPRLELRPRPHQAPRSRALVVHIH 
GGGFVAQTSKSHEPYLKNWAQELGVPIFSIDYSLAPEAPFPRALEECFFAYCWAVKHC 
DLLGSTGERICLAGDSAGGNLCITVSLRAAAYGVRVPDGIMAAYPVTTLQSSASPSRL 
LSLMDPLLPLSVLSKCVSAYSGTEAEDHFDSDQKALGVMGLVQRDTSLFLRDLRLGAS 
SWLNSFLELSGRKPQKTTSPTAESVRPTESMRRSVSEAALAQPEGLLGTDTLKKLTIK 
DLSNSEPSDSPEMSQSMETLGPSTPSDVNFFLRPGNSQEEAEAKDEVRPMDGVPRVRA 
AFPEGFHPRRSSQGVLHMPLYTSPIVKNPFMSPLLAPDSMLKTLPPVHLVACALDPML 
DDSVMFARRLRDLGQPVTLKVVEDLPHGFLSLAALCRETRQATEFCVQRIRLILTPPA 
APLN 
 
